Catecholaminergic-cholinergic interaction in the basal forebrain.
Záborszky
L
L
Department of Neurology, University of Virginia, Charlottesville.
Cullinan
W E
WE
Luine
V N
VN
D000109:Acetylcholine / Q000502:physiology*; D000344:Afferent Pathways / Q000502:physiology / Q000648:ultrastructure; D000818:Animals; D015415:Biomarkers; D001931:Brain Mapping; D002395:Catecholamines / Q000502:physiology*; D002795:Choline O-Acetyltransferase / Q000032:analysis; D002799:Cholinergic Fibers / Q000502:physiology / Q000648:ultrastructure; D004298:Dopamine / Q000502:physiology; D004299:Dopamine beta-Hydroxylase / Q000032:analysis; D006801:Humans; D008322:Mammals / Q000033:anatomy & histology / Q000502:physiology; D009419:Nerve Tissue Proteins / Q000032:analysis; D009474:Neurons / Q000737:chemistry; D009638:Norepinephrine / Q000502:physiology; D016548:Prosencephalon / Q000502:physiology*; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis
D015415:Biomarkers; D002395:Catecholamines; D009419:Nerve Tissue Proteins; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D002795:Choline O-Acetyltransferase; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine